Rural Area Pharmacist Intervention for Diabetes
The goal of the project is to inform the system leaders regarding the feasibility and utility of having an embedded telehealth-based clinical pharmacist at rural primary care practices for supportive disease management of patients with Type 2 diabetes (T2D) and whether continuing and expanding the program within the system is worthwhile.
Conditions:
🦠 Type 2 Diabetes
🗓️ Study Start (Actual) 16 May 2023
🗓️ Primary Completion (Estimated) September 2024
✅ Study Completion (Estimated) September 2024
👥 Enrollment (Estimated) 240
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Winston-Salem, North Carolina, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Age \>= 18 years and \<=75 years (since children have different incidence, management, and outcomes of Type 2 diabetes (T2D) compared to adults and older adults aged more than 75 years may have had their hemoglobin A1C (HbA1c) goals adjusted to higher thresholds)
    • * HbA1c reading ≥ 8% recorded during 6 months prior to or up to 9 days after the encounter at the participating practices
    • * Uncontrolled type 2 diabetes (ICD-10-CM code E11.XX) recorded in the EHR in the year prior to up to 1 week after the uncontrolled HbA1c reading

    Exclusion Criteria:

    • * Patients with gestational or type 1 diabetes
    • * Those enrolled in any other chronic disease management programs delivered by non-physician healthcare professionals
    • * Those receiving T2D care from an endocrinologist
    • * Those receiving long term, hospice, or palliative care services
    • * Those with serious mental illnesses (schizophrenia and other psychotic disorders, major depressive disorders, bipolar disorders, and borderline personality disorder)
    • * Those with malignant cancer
    • * Those with cognitive impairment
Ages Eligible for Study: 18 Years to 75 Years (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 27 February 2023
  • First Submitted that Met QC Criteria 27 February 2023
  • First Posted 9 March 2023

Study Record Updates

  • Last Update Submitted that Met QC Criteria 28 May 2024
  • Last Update Posted 29 May 2024
  • Last Verified February 2024